$Zura Bio (ZURA.US)$
Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis

$Zura Bio (ZURA.US)$ big move ahead. daily chart looks great

$Zura Bio (ZURA.US)$ Zura Bio Ltd: Tibulizumab (Zb-106) Was Well Tolerated and Neutralized Il-17a and Baff in a Phase 1 Study in Patients With Sjogren's Syndrome! Presents data at EULAR 2024

$Zura Bio (ZURA.US)$  One is overweight and another to buy 🤫

$Zura Bio (ZURA.US)$
Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024
Zura Bio, a clinical-stage immunology company, announced its scheduled presentation at EULAR 2024 in Vienna from June 12-15. The company will unveil data on tibulizumab (ZB-106), a dual-pathway antibody targeting IL-17A and BAFF, focusing on its potential for treating Sjogren's syndrome and rheumatoid arthritis. The data aims to ...

$Zura Bio (ZURA.US)$ SC 13G: Statement of acquisition of beneficial ownership by individuals-Venrock Healthcare Capital Partners III, L.P.(9.99%),VHCP Co-Investment Holdings III, LLC(9.99%), etc.
SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(5.1%),Peter Kolchinsky(5.1%), etc.

$Zura Bio (ZURA.US)$
NEWS
Zura Bio Raises $112.5M Through Private Placement Deal

$Zura Bio (ZURA.US)$
NEWS
Zura Bio Announces Oversubscribed $112.5 Million Private Placement

$Two (TWOA.US)$ Good morning Traders in the world Good Luck to you all 👋 $Intelligent Group (INTJ.US)$ $Fractyl Health (GUTS.US)$ $Eyenovia (EYEN.US)$ $Zura Bio (ZURA.US)$ $Haoxi Health Technology (HAO.US)$ $Jin Medical International (ZJYL.US)$